Skip to content
OpenCapital
Get started

Immunovant, Inc. IMVT United Kingdom — Total loss before income taxes

Other geography segments

Switzerland
-$606.29M-53.4%
United States
$100.99M+670%
Bermuda
-$39K+61.0%

Similar metrics at other companies

EMCOR Group logo
EMEUNITED KINGDOM — Operating income (loss)
$0-100%
StoneX Group Inc. logo
SNEXUnited Kingdom — Foreign tax expense
$2.38M-72.5%
Sun Communities logo
SUIUK — Operating Income (Loss)
$18M+5.9%
Sunoco logo
SUNUNITED STATES — Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
$99.25M-61.8%
Sunoco logo
SUNNon-US — Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
$48M+2,033%
Energy Transfer logo
ETNon-US — Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
$47.25M+3,680%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0×0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s united kingdom — total loss before income taxes.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s united kingdom — total loss before income taxes?
Immunovant, Inc. (IMVT) reported united kingdom — total loss before income taxes of -$13.75K in Q1 2026.
What is the long-term trend for Immunovant, Inc.'s united kingdom — total loss before income taxes?
Over 4 years (2022 to 2026), Immunovant, Inc.'s united kingdom — total loss before income taxes has grown at a 129.0% compound annual growth rate (CAGR), from -$2K to -$55K.
What does united kingdom — total loss before income taxes mean?
This metric represents the pre-tax financial loss generated specifically by operations within the United Kingdom geographic segment. It reflects the net result of revenues and expenses incurred in this region before accounting for income tax provisions. Monitoring this figure helps investors assess the regional profitability profile and the burn rate associated with international clinical development or administrative activities.